9_y_PoFP0cI https://histock.tw/talk/live.aspx?name=gtalk&id=1314 20250226 阿布波

台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    99.3
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    3,774
  • 產業
    上櫃 生技醫療類股
  • 319人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
中裕 (4147)籌碼相關-永豐金-竹北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-竹北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/242101.50120100.1999.30-1181,796-6.57% 大賣/鉅額交易
2025/02/212102.70699.1098.90-41,727-0.23%
2025/02/20295.6000.0099.7021,5530.13%
2025/02/1700.007107.2197.10-71,440-0.49%
2025/02/14397.53199.5098.9021,2260.16%
2025/02/07289.3000.0090.1021,1250.18%
2025/02/05184.2000.0084.3011,1080.09%
2025/01/22184.5000.0084.9011,1160.09%
2025/01/13194.60192.4089.9001,1320.00%
2025/01/10289.3000.0090.5021,0640.19%
2025/01/09690.674989.1687.50-431,014-4.24%
2025/01/084100.755101.2097.20-1872-0.11%
2025/01/0700.00292.1092.70-2649-0.31%
2025/01/0600.00190.2089.80-1611-0.16%
2024/12/250.583.2000.0083.900.55890.08%
2024/12/202882.4400.0082.10286134.56%
2024/12/091889.7400.0090.10186003.00%
2024/12/061088.001189.3487.60-1573-0.17%
2024/12/021885.4400.0084.20185243.43%
2024/11/11179.9000.0082.4015330.19%
2024/11/080.980.5000.0080.100.95220.16%
2024/11/0500.00081.9081.6005370.00%
2024/10/170.375.3000.0075.000.35910.04%
2024/10/0700.00278.3077.80-2629-0.32%
2024/09/10079.8000.0079.9006930.00%
2024/08/070.575.8000.0075.600.57790.06%
2024/08/0600.00172.1070.30-1771-0.13%
2024/07/31183.20183.0082.6007320.00%
2024/07/23786.7000.0086.5077460.94%
2024/07/2200.00187.8087.10-1745-0.13%
2024/07/183788.1400.0088.40377095.21%
2024/07/171786.65188.4088.10167132.24%
2024/07/164086.70186.0085.60397205.42%
2024/06/2100.00189.0088.90-11,121-0.09%
2024/06/1300.00191.1091.00-11,164-0.09%
2024/06/1100.001.292.9291.00-1.21,182-0.10%
2024/06/050.189.8000.0090.300.11,2370.01%
2024/06/040.189.8000.0089.500.11,3170.01%
2024/05/23188.10187.7087.1002,0140.00%
2024/05/2100.00189.3088.00-12,123-0.05%
2024/05/06188.7000.0088.0012,3310.04%
2024/05/0300.00186.1085.80-12,318-0.04%
2024/05/0200.00185.1085.00-12,321-0.04%
2024/04/29183.80284.1086.00-12,338-0.04%
2024/04/245.184.15484.7084.801.12,3210.05%
2024/04/23282.9000.0082.8022,3280.09%
2024/04/1200.00194.1094.00-12,339-0.04%
2024/04/10196.10195.1093.2002,3390.00%
2024/04/0800.00190.7093.00-12,236-0.04%
2024/04/03190.60292.4090.60-12,195-0.05%
2024/04/02290.40288.5088.5002,0880.00%
2024/04/01290.30290.1090.1002,0740.00%
2024/03/22188.6000.0088.8012,0200.05%
2024/03/2100.00188.6088.60-12,014-0.05%
2024/03/201.290.9500.0089.401.22,0020.06%
2024/03/15190.8000.0090.1011,9700.05%
2024/03/1400.00191.5091.70-11,960-0.05%
2024/03/115095.9100.0094.10501,9072.62%
2024/03/0800.005396.9696.80-531,865-2.84%
2024/03/073105.5000.00107.5031,7970.17%
2024/03/040110.5000.00109.0001,6410.00%
2024/02/291112.008110.50110.50-71,559-0.45%
2024/02/271113.006114.08114.00-51,413-0.35%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章